We have investigated the specific immune response to Epstein-Barr virus (EBV) of peripheral blood mononuclear cells (PBMC) from patients with malignant lymphoma of the thyroid.
Malignant lymphoma of the thyroid occurs at the rate of 5% among thyroid neoplasms (Stauton et al., 1973) , and most prove to be cases of B-cell lymphoma (Maurer et al., 1979; Aozasa et al., 1986) .
The ubiquitious Epstein-Barr virus (EBV), which can readily transform normal human B-cells in vitro to blast cells with infinite replicative ability, frequently leads to a selflimiting lymphoproliferative disease, e. g., infectious mononucleosis (Henle and Henle, 1981) . The EBV may also be implicated in the etiology of some cases of Burkitt's lymphoma (Old et al., 1966) and nasopharyngeal carcinoma (Tamada et al., 1984) . Polyclonal and monoclonal B-cell lymphomas induced by EBV have occurred after infectious mononucleosis (Abo et al., 1982) and renal transplantation (Hanto et al., 1983) . Moreover, the EBV antibody titers in patients with malignant lymphoma exceed those observed in patients with Hashimoto's thyroiditis (Matsubayashi et al., 1987 for 50 days. Half the medium was changed every 3-5 days.
Transformed B-cell lines (EBVNA positive) detected by an anti-complement immunofluorescent method (Katsuki and Hinuma, 1975) were judged to be positive for EBV. There were 5 wells for each dilution.
Statistical analysis Wilcoxon's rank-sum test was used for statistical analysis.
Results

EBV antibodies
The results of tests for antibodies to EBVCA, EBVEA, and EBVNA are shown in Table 1 . All six patients and seven controls had EBVCA and EBVNA antibodies in the serum.
The titers of anti-EBVCA, EBVEA, and EBVNA in two groups were similar.
EBV-specific immune response The incidence of transformation in the well culture of PBMC infected by EBV is shown in (Burke et al., 1977 , Holm et al., 1985 Kato et al., 1985) .
However, the factors that transform the In susceptible persons,EBV infects Bcells, followed by extensive proliferation of suppressor/cytotoxic T-cells (De Waele et al., 1981) ; such cells help control the transformation of infected B-cells . Abo et al. (1982) have suggested that monoclonal malignant lymphoma arises after infectious mononucleosis as a result of EBV infection. It is well-known that clonal B-cell expression and malignant occur in immunosuppressed patients (Fenn, 1986) .
On the other hand, EBV infection has been thought to be a causative factor in a subtype of both malignant nonHodgkin's lymphoma (Wultzler et al., 1986) and Hodgkin's lymphoma (Weiss et al., 1987 , Staal et al., 1989 (Matsubayashi et al., 1987) . These important in the development of malignant lymphoma of the thyroid, either as a pathogenetic factor or as a consequence of the disease.
In this study, we found a significant decrease in the EBV-specific immune response due to outgrowth inhibition (i. e., a long-term T-cell mediated immune reaction of PBMC to EBV measured by an EBV-induced B-cell focus-regression assay), as well as a slight tendency for EBV to be found more frequently in mouthwash samples in patients with malignant lymphoma of the thyroid than in EBV-seropositive healthy subjects.
It is not yet evident whether these observations relate to the cause of the malignant lymphoma of the thyroid or are a consequence of it. If the former, it is possible that the impaired suppressor/cytotoxic T-cell response to EBV in the PBMC from patients with malignant lymphoma of the thyroid may allow EBV to readily proliferate. Conversely, if these effects are a consequence of the disease, then the decrease in EBV specific suppressor/ cytotoxic function may reflect a vicious circle resulting in proliferation of B-cells in this disease. EBV is a common virus and could be present in lymphoreticular tissue (such as lymph nodes, tonsils and Hashimoto's thyroiditis), through the oral cavity and might transform B-cells in the neck region. To suggest a direct role of EBV infection in the development of malignant lymphoma of the thyroid, it would be necessary to find proviral DNA in the nuclei of the tumor cells of such lymphomas.
